DK1284740T3 - Profylaktisk og terapeutisk behandling af infektiöse sygdomme, autoimmunsygdomme og allergiske sygdomme med monosaccharidbaserede forbindelser - Google Patents

Profylaktisk og terapeutisk behandling af infektiöse sygdomme, autoimmunsygdomme og allergiske sygdomme med monosaccharidbaserede forbindelser

Info

Publication number: DK1284740T3
Authority: DK; Denmark
Prior art keywords: autoimmune; monosaccharide; prophylactic; infectious; therapeutic treatment
Prior art date: 2000-05-19

Application number

DK01948222T

Other languages

English (en)

Inventor

David H Persing

J Terry Ulrich

David A Johnson

Jory R Baldridge

Richard Thomas Crane

Gary T Elliot

Michael J Lacy

Rong Wang

Original Assignee

Corixa Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-19

Filing date

2001-05-18

Publication date

2008-08-04

2001-05-18 Application filed by Corixa Corp filed Critical Corixa Corp

2008-08-04 Application granted granted Critical

2008-08-04 Publication of DK1284740T3 publication Critical patent/DK1284740T3/da

Links

208000023275 Autoimmune disease Diseases 0.000 title abstract 2
208000035473 Communicable disease Diseases 0.000 title 1
208000026935 allergic disease Diseases 0.000 title 1
230000001363 autoimmune Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
230000002458 infectious effect Effects 0.000 title 1
150000002772 monosaccharides Chemical class 0.000 title 1
230000000069 prophylactic effect Effects 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1
206010027654 Allergic conditions Diseases 0.000 abstract 1
229910019142 PO4 Inorganic materials 0.000 abstract 1
125000004103 aminoalkyl group Chemical group 0.000 abstract 1
150000008271 glucosaminides Chemical class 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
239000010452 phosphate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Pulmonology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Epidemiology (AREA)
Crystallography & Structural Chemistry (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Neurology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Otolaryngology (AREA)
Transplantation (AREA)
AIDS & HIV (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)

DK01948222T 2000-05-19 2001-05-18 Profylaktisk og terapeutisk behandling af infektiöse sygdomme, autoimmunsygdomme og allergiske sygdomme med monosaccharidbaserede forbindelser DK1284740T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US20582000P	2000-05-19	2000-05-19
US28156701P	2001-04-04	2001-04-04
PCT/US2001/016327 WO2001090129A2 (en)	2000-05-19	2001-05-18	Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds

Publications (1)

Publication Number	Publication Date
DK1284740T3 true DK1284740T3 (da)	2008-08-04

Family

ID=26900794

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01948222T DK1284740T3 (da)	2000-05-19	2001-05-18	Profylaktisk og terapeutisk behandling af infektiöse sygdomme, autoimmunsygdomme og allergiske sygdomme med monosaccharidbaserede forbindelser

Country Status (21)

Country	Link
US (1)	US6800613B2 (da)
EP (2)	EP2000144A1 (da)
JP (1)	JP5004261B2 (da)
KR (1)	KR100829674B1 (da)
CN (1)	CN1606446A (da)
AT (1)	ATE395923T1 (da)
AU (3)	AU2001269695B2 (da)
BR (1)	BR0110975A (da)
CA (1)	CA2409221C (da)
CY (1)	CY1108211T1 (da)
DE (1)	DE60134134D1 (da)
DK (1)	DK1284740T3 (da)
ES (1)	ES2305086T3 (da)
HU (1)	HU230847B1 (da)
IL (3)	IL152935A0 (da)
MX (1)	MXPA02011486A (da)
NO (1)	NO331939B1 (da)
NZ (1)	NZ522755A (da)
PL (1)	PL206832B1 (da)
PT (1)	PT1284740E (da)
WO (1)	WO2001090129A2 (da)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040006242A1 (en) *	1999-02-01	2004-01-08	Hawkins Lynn D.	Immunomodulatory compounds and method of use thereof
US7915238B2 (en)	1999-02-01	2011-03-29	Eisai R & D Management Co., Ltd.	Immunomodulatory compounds and methods of use thereof
US6835721B2 (en)	1999-02-01	2004-12-28	Eisai Co., Ltd.	Immunomodulatory compounds and methods of use thereof
US20030105032A1 (en) *	2000-05-19	2003-06-05	Persing David H.	Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
US7709451B2 (en) *	2001-09-07	2010-05-04	Trustees Of Boston University	Method and composition for treating immune complex associated disorders
EP1302206A1 (en) *	2001-10-11	2003-04-16	Universitair Medisch Centrum Utrecht	Methods and means for the use of the adventitial toll-like receptor
US6911434B2 (en)	2002-02-04	2005-06-28	Corixa Corporation	Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
JP2005523902A (ja)	2002-02-04	2005-08-11	コリクサコーポレイション	感染症及び他の疾患の免疫効果化合物による予防及び治療処理
RU2340621C2 (ru)	2002-07-08	2008-12-10	Корикса Корпорейшн	Способы получения аминоалкилглюкозаминидфосфатов и дисахаридных иммуноэффекторов и их промежуточных соединений
US7960522B2 (en)	2003-01-06	2011-06-14	Corixa Corporation	Certain aminoalkyl glucosaminide phosphate compounds and their use
CA2512108C (en)	2003-01-06	2013-04-02	Corixa Corporation	Certain aminoalkyl glucosaminide phosphate compounds and their use
WO2005089122A2 (en) *	2004-03-05	2005-09-29	Mayo Foundation For Medical Education And Research	Animals with reduced body fat and increased bone density
AU2006207998A1 (en)	2005-01-27	2006-08-03	Novartis Vaccines And Diagnostics Inc.	A method for characterizing the efficacy of an agent targeting a primary cystic fibrosis defect
EP1874342B1 (en)	2005-04-26	2018-06-06	Eisai R&D Management Co., Ltd.	Compositions and methods for cancer immunotherapy
GB0510463D0 (en) *	2005-05-23	2005-06-29	Britania Pharmaceuticals Ltd	Improvements in or relating to organic materials
US7622128B2 (en) *	2005-12-13	2009-11-24	University Of Washington	Porphyromonas gingivalis 1435/1449 LPS as an immune modulator
PT2468300T (pt)	2006-09-26	2018-01-30	Infectious Disease Res Inst	Composição para vacina contendo adjuvante sintético
US20090181078A1 (en) *	2006-09-26	2009-07-16	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
US20090215710A1 (en) *	2007-09-24	2009-08-27	Reliance Life Sciences Pvt. Ltd.	Carbohydrate based toll-like receptor (tlr) antagonists
US20090136509A1 (en) *	2007-10-31	2009-05-28	Simon Blake	Use of Toll-Like Receptor 4 Antagonists for the Treatment or Prevention of Osteoarthritic Conditions
CN102481312B (zh)	2009-06-05	2015-07-15	传染性疾病研究院	合成的吡喃葡萄糖脂佐剂
EP2550362B1 (en)	2010-03-25	2017-01-04	Oregon Health&Science University	Cmv glycoproteins and recombinant vectors
DK2618842T3 (da)	2010-09-22	2019-07-01	Ena Therapeutics Pty Ltd	Hidtil ukendt immunstimulerende fremgangsmåde
GB201101331D0 (en)	2011-01-26	2011-03-09	Glaxosmithkline Biolog Sa	Compositions and uses
CA2832109C (en)	2011-06-10	2021-07-06	Oregon Health & Science University	Cmv glycoproteins and recombinant vectors
GB201113570D0 (en)	2011-08-05	2011-09-21	Glaxosmithkline Biolog Sa	Vaccine
EP2568289A3 (en)	2011-09-12	2013-04-03	International AIDS Vaccine Initiative	Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en)	2011-10-27	2016-08-02	International Aids Vaccine Initiative	Viral particles derived from an enveloped virus
US9241988B2 (en) *	2012-04-12	2016-01-26	Avanti Polar Lipids, Inc.	Disaccharide synthetic lipid compounds and uses thereof
KR102136433B1 (ko)	2012-05-16	2020-07-22	이뮨 디자인 코포레이션	Hsv-2 백신
EP2679596B1 (en)	2012-06-27	2017-04-12	International Aids Vaccine Initiative	HIV-1 env glycoprotein variant
ES2743465T3 (es)	2013-03-15	2020-02-19	Glaxosmithkline Biologicals Sa	Composición que contiene derivados fosfato de aminoalquil glucosaminida tamponados y su uso para potenciar una respuesta inmunitaria
EP2986303B1 (en)	2013-04-18	2020-02-26	Immune Design Corp.	Gla monotherapy for use in cancer treatment
US9463198B2 (en)	2013-06-04	2016-10-11	Infectious Disease Research Institute	Compositions and methods for reducing or preventing metastasis
EP2848937A1 (en)	2013-09-05	2015-03-18	International Aids Vaccine Initiative	Methods of identifying novel HIV-1 immunogens
US10058604B2 (en)	2013-10-07	2018-08-28	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers
KR20160127828A (ko)	2014-03-12	2016-11-04	글락소스미스클라인 바이오로지칼즈 에스.에이.	면역원성 리포솜 제형
KR20160132088A (ko)	2014-03-12	2016-11-16	글락소스미스클라인 바이오로지칼즈 에스.에이.	점막 전달용 리포솜 조성물
MA41414A (fr)	2015-01-28	2017-12-05	Centre Nat Rech Scient	Protéines de liaison agonistes d' icos
EP3069730A3 (en)	2015-03-20	2017-03-15	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en)	2015-03-23	2016-09-28	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers
WO2017013603A1 (en)	2015-07-21	2017-01-26	Glaxosmithkline Biologicals Sa	Adjuntive immunotherapy for the prevention or treatment of infectious disease
WO2017021912A1 (en)	2015-08-06	2017-02-09	Glaxosmithkline Intellectual Property Development Limited	Combined tlrs modulators with anti ox40 antibodies
EP3331565A1 (en)	2015-08-06	2018-06-13	GlaxoSmithKline Intellectual Property Development Ltd	Tlr4 agonists and compositions thereof and their use in the treatment of cancer
TW201716084A (zh)	2015-08-06	2017-05-16	葛蘭素史克智慧財產發展有限公司	組合物及其用途與治療
TWI704154B (zh)	2015-12-03	2020-09-11	英商葛蘭素史克智慧財產發展有限公司	新穎化合物
WO2017098421A1 (en)	2015-12-08	2017-06-15	Glaxosmithkline Intellectual Property Development Limited	Benzothiadiazine compounds
WO2017153952A1 (en)	2016-03-10	2017-09-14	Glaxosmithkline Intellectual Property Development Limited	5-sulfamoyl-2-hydroxybenzamide derivatives
JP2019510802A (ja)	2016-04-07	2019-04-18	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＤｅｖｅｌｏｐｍｅｎｔＬｉｍｉｔｅｄ	タンパク質調節物質として有用な複素環アミド
HRP20220936T1 (hr)	2016-04-07	2022-10-28	Glaxosmithkline Intellectual Property Development Limited	Heterociklički amidi korisni kao modulatori proteina
CA3023157A1 (en)	2016-05-05	2017-11-09	Glaxosmithkline Intellectual Property (No.2) Limited	Enhancer of zeste homolog 2 inhibitors
JP2019521166A (ja)	2016-07-20	2019-07-25	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＤｅｖｅｌｏｐｍｅｎｔＬｉｍｉｔｅｄ	Ｐｅｒｋ阻害剤としてのイソキノリン誘導体
KR20190090824A (ko)	2016-12-01	2019-08-02	글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드	암을 치료하는 방법
US11389465B2 (en)	2017-05-01	2022-07-19	Vanderbilt University	Phosphorylated hexaacyl disaccharides (PHADs) for treating or preventing infections
WO2019021208A1 (en)	2017-07-27	2019-01-31	Glaxosmithkline Intellectual Property Development Limited	USEFUL INDAZOLE DERIVATIVES AS PERK INHIBITORS
WO2019053617A1 (en)	2017-09-12	2019-03-21	Glaxosmithkline Intellectual Property Development Limited	CHEMICAL COMPOUNDS
CA3077337A1 (en)	2017-10-05	2019-04-11	Glaxosmithkline Intellectual Property Development Limited	Modulators of stimulator of interferon genes (sting)
US20210238172A1 (en)	2017-10-05	2021-08-05	Glaxosmithkline Intellectual Property Development Limited	Heterocyclic amides useful as protein modulators and methods of using the same
EP3728289B1 (en)	2017-12-21	2025-09-10	Axelia Oncology Pty Ltd	Optimised compounds
ES2985591T3 (es)	2018-02-12	2024-11-06	Inimmune Corp	Ligandos de receptores tipo Toll
GB201807924D0 (en)	2018-05-16	2018-06-27	Ctxt Pty Ltd	Compounds
WO2020030570A1 (en)	2018-08-06	2020-02-13	Glaxosmithkline Intellectual Property Development Limited	Combinations of an ox40 antibody and a tlr4 modulator and uses thereof
WO2020030571A1 (en)	2018-08-06	2020-02-13	Glaxosmithkline Intellectual Property Development Limited	Combinations of a pd-1 antibody and a tlr4 modulator and uses thereof
WO2020031087A1 (en)	2018-08-06	2020-02-13	Glaxosmithkline Intellectual Property Development Limited	Combination therapy
WO2020109365A1 (en)	2018-11-29	2020-06-04	Glaxosmithkline Biologicals Sa	Methods for manufacturing an adjuvant
KR20220026585A (ko)	2019-06-26	2022-03-04	글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드	Il1rap 결합 단백질
KR20220050873A (ko)	2019-06-26	2022-04-25	악셀리아 온콜로지 피티와이 리미티드	신규한 분자
GB201910305D0 (en)	2019-07-18	2019-09-04	Ctxt Pty Ltd	Compounds
GB201910304D0 (en)	2019-07-18	2019-09-04	Ctxt Pty Ltd	Compounds
KR20220035457A (ko)	2019-07-21	2022-03-22	글락소스미스클라인 바이오로지칼즈 에스.에이.	치료 바이러스 백신
WO2021018941A1 (en)	2019-07-31	2021-02-04	Glaxosmithkline Intellectual Property Development Limited	Methods of treating cancer
WO2021043961A1 (en)	2019-09-06	2021-03-11	Glaxosmithkline Intellectual Property Development Limited	Dosing regimen for the treatment of cancer with an anti icos agonistic antibody and chemotherapy
WO2021048081A1 (en)	2019-09-09	2021-03-18	Glaxosmithkline Biologicals Sa	Immunotherapeutic compositions
JP7280387B2 (ja)	2019-09-27	2023-05-23	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド	抗原結合タンパク質
CN114981265B (zh)	2019-12-18	2025-01-03	Ctxt私人有限公司	化合物
CN112999233B (zh) *	2019-12-19	2023-10-20	中国医学科学院药物研究所	一类来源于赤芍的单萜苷类化合物及其制法和应用
KR102906404B1 (ko) *	2020-03-13	2025-12-31	헤파이스토스-파마	해독된 지질다당류(lps), 천연 무독성 lps, 및 이의 용도
US20230234992A1 (en)	2020-06-05	2023-07-27	Glaxosmithkline Biologicals Sa	Modified betacoronavirus spike proteins
KR20230106604A (ko) *	2020-11-11	2023-07-13	다이이찌 산쿄 가부시키가이샤	신규 아미노알킬글루코사미니드 4-인산 유도체
EP4032547A1 (en)	2021-01-20	2022-07-27	GlaxoSmithKline Biologicals S.A.	Hsv1 fce derived fragements for the treatment of hsv
CN116917273A (zh)	2021-03-02	2023-10-20	葛兰素史克知识产权发展有限公司	作为dnmt1抑制剂的经取代的吡啶
JP2024511831A (ja)	2021-03-31	2024-03-15	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド	抗原結合タンパク質およびそれらの組み合わせ

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4769330A (en)	1981-12-24	1988-09-06	Health Research, Incorporated	Modified vaccinia virus and methods for making and using the same
US4603112A (en)	1981-12-24	1986-07-29	Health Research, Incorporated	Modified vaccinia virus
US4436727A (en)	1982-05-26	1984-03-13	Ribi Immunochem Research, Inc.	Refined detoxified endotoxin product
US4866034A (en)	1982-05-26	1989-09-12	Ribi Immunochem Research Inc.	Refined detoxified endotoxin
US4987237A (en)	1983-08-26	1991-01-22	Ribi Immunochem Research, Inc.	Derivatives of monophosphoryl lipid A
US4844894A (en)	1984-07-12	1989-07-04	Ribi Immunochem Research Inc.	Method of inhibiting the onset of septicemia and endotoxemia
GB8508845D0 (en)	1985-04-04	1985-05-09	Hoffmann La Roche	Vaccinia dna
US4777127A (en)	1985-09-30	1988-10-11	Labsystems Oy	Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
US4877611A (en)	1986-04-15	1989-10-31	Ribi Immunochem Research Inc.	Vaccine containing tumor antigens and adjuvants
GB8702816D0 (en)	1987-02-07	1987-03-11	Al Sumidaie A M K	Obtaining retrovirus-containing fraction
WO1989001973A2 (en)	1987-09-02	1989-03-09	Applied Biotechnology, Inc.	Recombinant pox virus for immunization against tumor-associated antigens
EP0324455A3 (en) *	1988-01-15	1991-03-27	Hans O. Ribi	Novel polymeric immunological adjuvants
AP129A (en)	1988-06-03	1991-04-17	Smithkline Biologicals S A	Expression of retrovirus gag protein eukaryotic cells
US4912094B1 (en)	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
JP4041535B2 (ja)	1989-08-18	2008-01-30	オックスフォードバイオメディカ（ユーケー）リミテッド	標的細胞にベクター構造体を運搬する組換レトロウィルス
AU660325B2 (en) *	1991-10-11	1995-06-22	Eisai Co. Ltd.	Anti-endotoxin compounds and related molecules and methods
ATE509102T1 (de)	1994-07-15	2011-05-15	Univ Iowa Res Found	Immunomodulatorische oligonukleotide
US6887483B2 (en) *	1995-12-01	2005-05-03	University Of Iowa Research Foundation	Non-toxic mutants of pathogenic gram-negative bacteria
US5762943A (en) *	1996-05-14	1998-06-09	Ribi Immunochem Research, Inc.	Methods of treating type I hypersensitivity using monophosphoryl lipid A
US5856462A (en)	1996-09-10	1999-01-05	Hybridon Incorporated	Oligonucleotides having modified CpG dinucleosides
US6491919B2 (en) *	1997-04-01	2002-12-10	Corixa Corporation	Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
US6113918A (en)	1997-05-08	2000-09-05	Ribi Immunochem Research, Inc.	Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6303347B1 (en) *	1997-05-08	2001-10-16	Corixa Corporation	Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6764840B2 (en) *	1997-05-08	2004-07-20	Corixa Corporation	Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6355257B1 (en)	1997-05-08	2002-03-12	Corixa Corporation	Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6368604B1 (en) *	1997-09-26	2002-04-09	University Of Maryland Biotechnology Institute	Non-pyrogenic derivatives of lipid A
GB9727262D0 (en)	1997-12-24	1998-02-25	Smithkline Beecham Biolog	Vaccine
IL138000A0 (en)	1998-04-09	2001-10-31	Smithkline Beecham Biolog	Adjuvant compositions
JP2002520373A (ja) *	1998-07-14	2002-07-09	アメリカン・サイアナミド・カンパニー	モノホスホリルリピドａを含有するアジュバントおよびワクチン組成物
US6013640A (en)	1998-08-21	2000-01-11	Ribi Immunochem Research, Inc.	Phosphoglycolipid and methods for its use
US6261573B1 (en) *	1998-10-30	2001-07-17	Avant Immunotherapeutics, Inc.	Immunoadjuvants
AU762369B2 (en) *	1998-11-03	2003-06-26	De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur	LPS with reduced toxicity from genetically modified gram negative bacteria
WO2001010221A1 (en) *	1999-08-06	2001-02-15	Corixa Corporation	Vaccines for the treatment of autoimmune disease
WO2001034794A1 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Biologicals S.A.	Casb7434, an antigen over-expressed in colon cancer
US6699846B2 (en) *	2000-03-17	2004-03-02	Corixa Corporation	Mono- and disaccharides for the treatment of nitric oxide related disorders

2001
- 2001-05-18 EP EP08153476A patent/EP2000144A1/en not_active Withdrawn
- 2001-05-18 PL PL365169A patent/PL206832B1/pl not_active IP Right Cessation
- 2001-05-18 CN CNA018114881A patent/CN1606446A/zh active Pending
- 2001-05-18 DE DE60134134T patent/DE60134134D1/de not_active Expired - Lifetime
- 2001-05-18 HU HU0301815A patent/HU230847B1/hu unknown
- 2001-05-18 WO PCT/US2001/016327 patent/WO2001090129A2/en not_active Ceased
- 2001-05-18 PT PT01948222T patent/PT1284740E/pt unknown
- 2001-05-18 KR KR1020027015626A patent/KR100829674B1/ko not_active Expired - Lifetime
- 2001-05-18 JP JP2001586316A patent/JP5004261B2/ja not_active Expired - Lifetime
- 2001-05-18 AT AT01948222T patent/ATE395923T1/de active
- 2001-05-18 MX MXPA02011486A patent/MXPA02011486A/es active IP Right Grant
- 2001-05-18 BR BR0110975-8A patent/BR0110975A/pt not_active IP Right Cessation
- 2001-05-18 CA CA2409221A patent/CA2409221C/en not_active Expired - Lifetime
- 2001-05-18 AU AU2001269695A patent/AU2001269695B2/en not_active Expired
- 2001-05-18 NZ NZ522755A patent/NZ522755A/en not_active IP Right Cessation
- 2001-05-18 DK DK01948222T patent/DK1284740T3/da active
- 2001-05-18 IL IL15293501A patent/IL152935A0/xx unknown
- 2001-05-18 ES ES01948222T patent/ES2305086T3/es not_active Expired - Lifetime
- 2001-05-18 EP EP01948222A patent/EP1284740B1/en not_active Expired - Lifetime
- 2001-05-18 US US09/861,466 patent/US6800613B2/en not_active Expired - Lifetime
- 2001-05-18 AU AU6969501A patent/AU6969501A/xx active Pending
2002
- 2002-11-19 IL IL152935A patent/IL152935A/en unknown
- 2002-11-19 NO NO20025543A patent/NO331939B1/no not_active IP Right Cessation
2007
- 2007-05-11 AU AU2007202117A patent/AU2007202117B2/en not_active Expired
- 2007-10-08 IL IL186495A patent/IL186495A/en active IP Right Grant
2008
- 2008-07-24 CY CY20081100772T patent/CY1108211T1/el unknown

Also Published As

Publication number	Publication date
NZ522755A (en)	2004-05-28
EP1284740A2 (en)	2003-02-26
EP2000144A1 (en)	2008-12-10
AU2007202117A1 (en)	2007-05-31
ES2305086T3 (es)	2008-11-01
WO2001090129A3 (en)	2002-06-06
US6800613B2 (en)	2004-10-05
PL206832B1 (pl)	2010-09-30
AU2007202117B2 (en)	2011-01-27
NO20025543L (no)	2003-01-08
HU230847B1 (en)	2018-08-28
AU2001269695B2 (en)	2007-02-15
WO2001090129A2 (en)	2001-11-29
ATE395923T1 (de)	2008-06-15
CN1606446A (zh)	2005-04-13
NO331939B1 (no)	2012-05-07
PT1284740E (pt)	2008-07-09
CA2409221A1 (en)	2001-11-29
DE60134134D1 (de)	2008-07-03
US20020077304A1 (en)	2002-06-20
IL186495A (en)	2010-12-30
PL365169A1 (en)	2004-12-27
KR100829674B1 (ko)	2008-05-16
IL152935A (en)	2009-08-03
NO20025543D0 (no)	2002-11-19
EP1284740B1 (en)	2008-05-21
JP2004508292A (ja)	2004-03-18
AU6969501A (en)	2001-12-03
IL152935A0 (en)	2003-06-24
KR20030031485A (ko)	2003-04-21
HUP0301815A2 (hu)	2003-09-29
BR0110975A (pt)	2004-03-23
CA2409221C (en)	2010-10-26
MXPA02011486A (es)	2004-01-26
JP5004261B2 (ja)	2012-08-22
IL186495A0 (en)	2008-01-20
CY1108211T1 (el)	2014-02-12
HUP0301815A3 (en)	2009-08-28

Publication	Publication Date	Title
DK1284740T3 (da)	2008-08-04	Profylaktisk og terapeutisk behandling af infektiöse sygdomme, autoimmunsygdomme og allergiske sygdomme med monosaccharidbaserede forbindelser
ATE420947T1 (de)	2009-01-15	Gewebeimplant zur wiederherstellung von knorpelgewebe
ATE441663T1 (de)	2009-09-15	Verfahren und zusammensetzungen für amyloidosis- verbundene krankheiten
UA81676C2 (ru)	2008-01-25	Композиция для лечения инфекций у крупного рогатого скота и свиней
EA200201247A1 (ru)	2003-10-30	Соединения для лечения болезни альцгеймера
ATE472325T1 (de)	2010-07-15	Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
ID26043A (id)	2000-11-16	Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
FIU20060389U0 (fi)	2006-09-22	Luusairauksien hoito
BR0212898A (pt)	2004-10-13	Método de tratamento de infecções do ouvido médio
DK1381382T3 (da)	2009-02-02	Fremgangsmåder og præparater til behandling af öjensygdomme
DE60220220D1 (de)	2007-07-05	Blutbehandlungssystem
ID27276A (id)	2001-03-22	Oksazolidinon-oksazolidinon untuk merawat infeksi-infeksi mata
PT874843E (pt)	2002-12-31	4-(1h-benzimidazol-2-il)¬1,4\|diazepinos substituidos uteis para o tratamento de doencas alergicas
DK0948967T3 (da)	2005-02-14	Behandling af virussygdom hos svin
ATE375168T1 (de)	2007-10-15	Die synergistischen wirkungen von hgf und antibakterieller behandlung
DK1222854T3 (da)	2011-03-14	Forebyggelse og behandling af sygdomme forbundet med blodkoagulering
DK1133296T3 (da)	2003-11-17	Ny terapeutisk anvendelse af nicergolin
DE60112768D1 (de)	2005-09-22	Behandlung von entzündlichen erkrankungen
DK1286686T3 (da)	2007-11-19	E-selectin til behandling og forebyggelse af slagtilfælde
EA200200987A1 (ru)	2003-04-24	Лечение заболеваний, связанных с серотонинергической системой
DE60111519D1 (de)	2005-07-21	Chemische modifizierung von harn von säugern
DK1133297T3 (da)	2003-11-24	Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin
BR0001620A (pt)	2001-12-04	Conjunto de rodas para andador infantil
UA25252A (uk)	1998-12-25	Хірургічhий спосіб лікуваhhя захворюваhь артерій hижhіх кіhцівок
UA25527A (uk)	1998-12-25	Спосіб лікуваhhя гhійhої іhфекції м'яких ткаhиh